World-class Industry Scale Platform

Different from standard toxicology study in monkeys, NHP pharmacology studies engage significantly more and complicated procedures in the animal training, model induction, dosing regimen, sample collection, test, measurement, scoring, extra care and treatment, plus, the clinical relevant protocols frequently required, including biopsy, endoscopy, surgery, invasive treatment, and imaging, etc. Since 2011 Prisys has been striving to build its NHP pharmacology with the integration of animal resources, clinical technologies, industrial scale, and high-end animal welfare, to provide the world-class platform that can carry out various NHP pharmacology studies in both easy access and economic ways for pharmaceutical development. Prisys’ new NHP study center, after over a year’s dedicated design, will stand out as an unique “NHP general hospital”, with 4,000 square meters (43,000 square feet) space of fully incorporated study capabilities and disease specifically designated laboratories for efficient studies of new medicines in NHP models. Prisys Shanghai NHP R&D center is expected to start operation in mid 2020.